Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors.

Rijo, Patricia; Athanassopoulos, Constantinos M; Carpinella, María Cecilia

Rijo, Patricia; Athanassopoulos, Constantinos M; Carpinella, María Cecilia.

Afiliação

Rijo P; CBIOS-Universidade Lusófona Research Center for Biosciences & Health Technologies, Lisbon, Portugal.
Athanassopoulos CM; Faculty of Pharmacy, Instituto de Investigação do Medicamento (iMed.ULisboa), University of Lisbon, Lisbon, Portugal.
Carpinella MC; Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, Patras, Greece.

Front Pharmacol ; 13: 1108252, 2022.

Article em En | MEDLINE | ID: mdl-36569312

Palavras-chave

cancer therapy; multidrug resistant (MDR) tumors; phytochemicals; plant-derived compounds; synthetic derivatives

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article